Archives
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Immune-Evasive Red Fl...
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Immune-Evasive Red Fluorescent Reporter Gene
Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA encoding the monomeric red fluorescent protein mCherry, derived from Discosoma sp. DsRed (APExBIO). This 996-nt mRNA features Cap 1 capping and incorporates 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) to reduce innate immune activation, enhance stability, and prolong in vivo half-life (Roach 2024). Delivered at 1 mg/mL in sodium citrate buffer (pH 6.4), it is optimized for molecular imaging, cell localization, and robust protein expression in research workflows. Benchmark studies show improved translation efficiency and immune evasion relative to unmodified mRNA controls (Roach 2024).
Biological Rationale
mCherry is a monomeric red fluorescent protein (RFP) engineered from Discosoma sp. DsRed, commonly used as a molecular marker for protein localization and gene expression studies (APExBIO). The mRNA encoding mCherry provides a non-integrating reporter gene solution, avoiding genomic insertional mutagenesis. Synthetic mRNA enables rapid, transient protein expression and is suitable for primary cells, stem cells, and difficult-to-transfect lines (see also). Cap 1 structure and nucleotide modifications (5mCTP, ψUTP) further reduce immunogenicity and stabilize the transcript, supporting applications in sensitive or immune-competent models (as discussed in).
Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)
- Cap 1 Capping: The enzymatically added Cap 1 structure (via Vaccinia virus Capping Enzyme, GTP, S-adenosylmethionine, and 2′-O-Methyltransferase) mimics native mammalian mRNA, enhancing ribosomal recognition and translation initiation (Roach 2024).
- Nucleotide Modifications: Incorporation of 5mCTP and ψUTP suppresses innate immune sensors (TLR7/8, RIG-I/MDA5), reducing type I interferon responses and cytotoxicity (Roach 2024).
- Poly(A) Tail: A synthetic polyadenylated tail increases mRNA stability and translation efficiency by promoting ribosome recycling (Roach 2024).
- Protein Encoding: mCherry expressed from this mRNA has an excitation maximum at ~587 nm and emission maximum at ~610 nm, providing robust red fluorescence (FPbase).
Evidence & Benchmarks
- Cap 1-mRNA with 5mCTP/ψUTP modifications shows significantly reduced innate immune activation (e.g., lower IFN-β, IL-6 secretion) compared to unmodified mRNA in mammalian cells (Roach 2024, Fig. 5-7).
- Fluorescence microscopy confirms high mCherry expression in vitro, with detectable signal persisting for ≥48 hours post-transfection in human cell lines (Roach 2024, Table 2).
- Poly(A)-tailed, Cap 1-capped mRNA demonstrates a >2-fold increase in translation efficiency over Cap 0 or untailed transcripts under controlled conditions (Roach 2024, Methods).
- Stability assays show EZ Cap™ mCherry mRNA (5mCTP, ψUTP) remains functional after storage at -40°C for at least 6 months (APExBIO).
- Reporter mRNA is compatible with lipid nanoparticle and polymeric mesoscale nanoparticle delivery systems, retaining signal and function (Roach 2024, Results).
This article updates and extends the mechanistic details on immune evasion and translation efficiency discussed in Redefining Reporter Gene Strategies: Mechanistic and Strategic Advances by providing specific stability and benchmarking data for EZ Cap™ mCherry mRNA (5mCTP, ψUTP) in nanoparticle systems.
Applications, Limits & Misconceptions
- Applications:
- Transient fluorescent labeling of live or fixed cells for localization studies.
- Reporter gene in transfection optimization and delivery validation assays.
- Tracking of mRNA nanoparticle delivery efficiency in vitro/in vivo (Roach 2024).
- Functional imaging in primary cells or stem cells due to low immunogenicity.
- Limits:
- Not suitable for stable, long-term gene expression beyond several days (due to mRNA degradation).
- Requires -40°C or lower storage to maintain full activity.
- Not intended for direct therapeutic applications in humans or animals (research use only).
Common Pitfalls or Misconceptions
- Assuming Cap 1 mRNA is fully non-immunogenic—residual innate responses may occur in some primary immune cells.
- Expecting stable, genomic integration—mRNA acts only transiently and does not integrate into DNA.
- Using improper storage (e.g., above -40°C) leads to rapid loss of activity.
- Confusing mCherry wavelength with excitation/emission maxima: excitation ≈ 587 nm, emission ≈ 610 nm (FPbase).
- Assuming all delivery vehicles are equally compatible—formulation and charge may affect uptake and expression (Roach 2024).
Workflow Integration & Parameters
- Thaw mRNA aliquots rapidly on ice; avoid repeated freeze-thaw cycles.
- Use in vitro transfection reagents (e.g., lipid nanoparticles, electroporation) validated for mRNA delivery.
- Typical working concentrations: 0.1–2 μg per 105 cells, depending on cell type and application.
- Monitor fluorescence by microscopy or flow cytometry within 4–24 hours post-transfection.
- Store unused product at or below -40°C in 1 mM sodium citrate, pH 6.4, as supplied by APExBIO.
This article clarifies specific workflow parameters and storage requirements not fully detailed in mCherry mRNA with Cap 1 Structure: Protocols & Advanced Applications.
Conclusion & Outlook
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) from APExBIO represents a robust, immune-evasive reporter gene solution for advanced cell biology and nanoparticle delivery research. Its Cap 1 capping and modified nucleotides confer superior stability and translation, while minimizing innate immune activation. Future advances may further optimize delivery vehicles or enable multiplexed fluorescent tracking in complex systems. For a complete technical overview or to purchase, visit the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.
This review expands on the practical and mechanistic benchmarks outlined in Applied Strategies with mCherry mRNA by providing detailed, citation-backed evidence for immune evasion and workflow integration.